Abstract
The majority of the impaired symptoms in hypoglycaemia unawareness, such as palpitations, tachycardia and tremor, are caused by increased release of adrenaline (ADR) and noradrenaline (NA), and induced by stimulation of β-adrenergic receptors. Binding of ADR or NA to the β-adrenergic receptor generates a signal, transmitted via a guanine nucleotide binding protein complex (G-protein), which in turn activates adenylate cyclase with increased production of cAMP. The aim of this study was to show whether IDDM-patients with hypoglycaemia unawareness had deficient coupling between β2-adrenergic receptors and G-proteinscompared to IDDM-patients with hypoglycaemia awareness and healthy controls. The IDDM-patients were subgrouped as hypoglycaemia aware or unaware based on questionnaire answers, clinical information and the results of isoprenaline sensitivity tests. Mononuclear leukocytes (MNL) were isolated from venous blood. By saturation binding experiments, using [125I]-(-)-iodopindolol ((-)-IPIN), total receptor number (Bmax) and affinity (Kd) were determined. By displacement experiments the relative number of low-and high-affinity receptors for the β-adrenergic agonist (-)-isoprenaline ((-)-ISO) were determined. We found no difference in Bmax- or Kd-values for (-)-IPIN between the subgroups. However, there was a reduced capability to form high-affinity binding complexes with (-)-ISO in MNL from IDDM-patients with hypoglycaemia unawareness. It was concluded that hypoglycaemia unawareness in IDDM was associated with dysfunction of the proximal β2-adrenergic signal pathway.
Similar content being viewed by others
References
Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Puech J, Legrand JC (1988) Lack of hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin-dependent patients. J Clin Endocrin Metabol 66:273–278
Berlin I, Grimaldi A, Payan C, Sachon C, Bosquet F, Thervet F, Peuch AJ (1987) Hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care 10:742–747
Trovik TS, Jæger R, Jorde R, Sager G (1994) Reduced sensitivity to β-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycemia unawareness. Br J Clin Pharmacol 38:5,427–432
Serusclat P, Rosen SG, Smith EB, Shah SD, Clutter WE, Cryer PE (1983) Mononuclear leucocyte β2-adrenergic receptors and adenylate cyclase sensitivity in insulin-dependent diabetes mellitus. Diabetes 32:825–829
Sager G, Slørdal L, Huseby N-E, Florholmen J (1991) β-Adrenoceptor regulation in insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 51:283–288
Gerich JE, Mokan M, Veneman T, Korytkowski M, Mitrakou A (1991) Hypoglycemia unawareness. Endocrine Rev 12:4,356–371
Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303–307
Birnbaumer L (1990) Transduction of receptor signal into modulation of effector activity by G proteins: the first 20 years or so. FASEB J 4:3068–3078
George CF, Conolly ME, Fenyvesi T, Briant R, Dollery CT (1972) Intravenously administered isoproterenol sulfate doseresponse curves in man. Arch Intern Med 130:361–364
Bøyum A (1968) Isolation of mononuclear cells and granulo cytes from human blood. Scand J Clin Lab Invest 21 [Suppl 97]:77–89
Kent RS, DeLean A, Lefkowitz RJ (1980) A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol 17:14–23
DeLean A, Stadel J, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108–7117
Sager G (1990) Types of β-adrenergic binding sites on plasma proteins and blood cells. In: Belpaire F, Bogaert M, Tillement JP Verbeeck R (eds) Plasma binding of drugs and its consequences. Academia Press, Ghent, pp 43–53
Widom B, Simonson D (1990) Glycemic control, neuropsycologic function during hypoglycemia in patients with insulindependent diabetes. Ann Intern Med 112:904–912
Mokan M, Mitrakou A, Raptis G, Platanisiotis D, Grannakopoulos F, Korytkowski M, Cryer P, Gerich J (1991) Differential effects of duration of diabetes and glycemic control on thresholds and magnitudes of responses to hypoglycemia. Diabetes 40 [Suppl 1]:556A
Boyle P, Schwartz N, Shah S, Clutter W, Cryer P (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487–1492
Lohse MJ, Benovic JL, Caron MG, Lefkowitz RJ (1990) Multiple pathways of rapid β2-adrenergic receptor desensitization. J Biol Chem 265:3202–3209
Lynch CJ, Exton JH (1992) Alterations in G-protein-mediated cell signalling in diabetes mellitus. In: Milligan G, Wakelam M (eds) G-proteins. Signal, Transduction and Disease. Academic Press, London, pp 87–108
Kampa IS, Frascella DW, Hundertmark JM, Rosenberg JM, Reid V (1981) The effect of hyperthermic stress on blood glucagon levels in normal and diabetic rats. Horm Metab Res 13:122–122
Chang AY, Noble RE, Wyse BM (1977) Comparison of highly inbred diabetic and nondiabetic lines in the Upjohn colony of Chinese hamsters. Diabetes 26:1063–1071
Christensen NJ (1974) Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes 23:1–8
Tamborlane WV, Sherwin RS, Koivisto V, Hendler R, Genel M, Felig P (1979) Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes 28:785–788
Wasserman DH, Lickley HLA, Vranic M (1985) Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes. J Appl Physiol 59:1272–1281
Hayford JT, Danney MM, Hendrix JA, Thompson RG (1980) Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 29:391–398
Topper E, Gertner S, Amiel S, Press M, Genel M, Tamborlane WV (1985) Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes; reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion. Pediatr Res 19:534–536
Ingebretsen WR, Peralta C, Monsher M, Wagner LK, Ingebretsen CG (1981) Diabetes alters the myocardial cAMP-protein kinase cascade system. Am J Physiol 240:H375-H382
Miller TB Jr, Pradeiro M, Wolleben C, Bullman J (1981) A hypersensitivity of glycogen phosphorylase activation in hearts of diabetic rats. J Biol Chem 256:1748–1753
Miller TB Jr (1984) Phosphorylase activation hypersensitivity in hearts of diabetic rats. Am J Physiol 246: E134-E140
Grimaldi A, Bosquet F, Davidoff P, Digy J, Landault C, Therver F, Zoghbr F, Legrand J (1990) Unawareness of hypoglycemia by insulin-dependent diabetics. Horm Metab Res 22:90–95
Hepburn D, Patrick A, Eadington D, Ewing D, Frier B (1990) Unawareness of hypoglycemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabetic Med 7:711–717
Heller S, Herbert M, MacDonald I, Tatterstall R (1987) Influence of sympathetic nervous system on hypoglycemic warning symptoms. Lancet II:359–363
Keen H (1976) Glucose intolerance, diabetes mellitus, atherosclerosis; prospects for prevention. Postgrad Med J 52:445–451
Hoeldtke RD, Boden G, Shuman CR, Owen OE (1982) Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 96:459–462
Editorial (1987) Awareness of hypoglycemia in diabetes. Lancet II:371–372
The diabetes control and complications trial research group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450–459
Cryer PE (1992) Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious circle. Diabetes 41:255–260
Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, DiVincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB (1993) Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683–1689
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trovik, T.S., Vaartun, A., Sager, G. et al. Dysfunction in the β2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia. Eur J Clin Pharmacol 48, 327–332 (1995). https://doi.org/10.1007/BF00194946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00194946